| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 绿色石化材料及新材料(元) | 2,886,495,425.40 | 5,289,697,017.99 | 1,961,670,531.26 | 3,869,137,887.41 | 1,554,092,288.67 |
| 明胶、胶原蛋白及其衍生品(元) | 206,043,602.83 | 331,658,600.87 | 168,287,345.50 | 483,574,027.92 | 249,805,524.44 |
| 生物医药及保健品(元) | - | - | 199,787,831.52 | 366,634,844.00 | 160,840,133.33 |
| 有机高分子复合材料(元) | 2,046,163,092.71 | 3,917,302,069.71 | 1,726,942,735.25 | 3,175,422,020.70 | 1,704,518,845.54 |
| 有机高分子改性材料(元) | 5,483,036,150.04 | 10,357,220,984.87 | 4,914,390,632.88 | 10,324,909,915.89 | 4,883,929,235.44 |
| 生物医药(空心胶囊)(元) | 207,167,320.35 | 411,768,449.46 | - | - | - |
| 营业成本(元) | |||||
| 绿色石化材料及新材料(元) | 2,535,929,376.30 | 4,980,838,232.71 | 1,866,605,633.32 | 3,681,771,711.44 | 1,490,946,433.91 |
| 明胶、胶原蛋白及其衍生品(元) | 169,747,078.39 | 260,139,425.56 | 127,925,529.76 | - | - |
| 生物医药及保健品(元) | - | - | 150,077,537.93 | - | - |
| 有机高分子复合材料(元) | 1,750,366,574.92 | 3,415,617,975.48 | 1,523,025,739.53 | 2,881,535,234.52 | 1,540,498,787.69 |
| 有机高分子改性材料(元) | 4,714,212,975.06 | 9,097,779,306.75 | 4,337,739,677.79 | 9,358,286,397.98 | 4,439,689,891.47 |
| 生物医药(空心胶囊)(元) | 159,225,388.83 | 316,175,604.02 | - | - | - |
| 毛利(元) | |||||
| 绿色石化材料及新材料(元) | 350,566,049.10 | 308,858,785.28 | 95,064,897.94 | 187,366,175.97 | 63,145,854.76 |
| 明胶、胶原蛋白及其衍生品(元) | 36,296,524.44 | 71,519,175.31 | 40,361,815.74 | - | - |
| 生物医药及保健品(元) | - | - | 49,710,293.59 | - | - |
| 有机高分子复合材料(元) | 295,796,517.79 | 501,684,094.23 | 203,916,995.72 | 293,886,786.18 | 164,020,057.85 |
| 有机高分子改性材料(元) | 768,823,174.98 | 1,259,441,678.12 | 576,650,955.09 | 966,623,517.91 | 444,239,343.97 |
| 生物医药(空心胶囊)(元) | 47,941,931.52 | 95,592,845.44 | - | - | - |
| 毛利率(%) | |||||
| 绿色石化材料及新材料(%) | 12.15 | 5.84 | 4.85 | 4.84 | 4.06 |
| 明胶、胶原蛋白及其衍生品(%) | 17.62 | 21.56 | 23.98 | - | - |
| 生物医药及保健品(%) | - | - | 24.88 | - | - |
| 有机高分子复合材料(%) | 14.46 | 12.81 | 11.81 | 9.26 | 9.62 |
| 有机高分子改性材料(%) | 14.02 | 12.16 | 11.73 | 9.36 | 9.10 |
| 生物医药(空心胶囊)(%) | 23.14 | 23.22 | - | - | - |
| 收入构成(%) | |||||
| 绿色石化材料及新材料(%) | 26.66 | 26.05 | 21.87 | 21.24 | 18.17 |
| 明胶、胶原蛋白及其衍生品(%) | 1.90 | 1.63 | 1.88 | 2.65 | 2.92 |
| 生物医药及保健品(%) | - | - | 2.23 | 2.01 | 1.88 |
| 有机高分子复合材料(%) | 18.90 | 19.29 | 19.25 | 17.43 | 19.93 |
| 有机高分子改性材料(%) | 50.63 | 51.00 | 54.78 | 56.67 | 57.10 |
| 生物医药(空心胶囊)(%) | 1.91 | 2.03 | - | - | - |
| 毛利构成(%) | |||||
| 绿色石化材料及新材料(%) | 23.38 | 13.81 | 9.84 | 12.94 | 9.41 |
| 明胶、胶原蛋白及其衍生品(%) | 2.42 | 3.20 | 4.18 | 0.00 | 0.00 |
| 生物医药及保健品(%) | - | - | 5.15 | 0.00 | 0.00 |
| 有机高分子复合材料(%) | 19.73 | 22.43 | 21.12 | 20.30 | 24.43 |
| 有机高分子改性材料(%) | 51.27 | 56.30 | 59.71 | 66.76 | 66.17 |
| 生物医药(空心胶囊)(%) | 3.20 | 4.27 | - | - | - |